Form D · Other Health Care
Dragonfly Endoscopy Inc.
Englewood,, CO · CIK 0001916614
Offering snapshot reported Mar 11, 2022 · SEC filing
- Reported sold
- $12.7M Offering amount: $12.7M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 22, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2022 | Initial | $12,681,690 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-436926
Source: Form D, filed Mar 11, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeremy Starkweather | Director, Executive |
| John Wynne | Director, Executive |
| Jason Ylizarde | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
9800 Pyramid Court Suite 400
Englewood,, CO, 80112
Englewood,, CO, 80112